Effect of a mindfulness training app on a cigarette quit attempt: an investigator-blinded, 58-county randomized controlled trial
JNCI Cancer Spectrum · 2023
DOI: 10.1093/jncics/pkad095 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift JNCI Cancer Spectrum, 2023. Verfasst von David S Black und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. Hauptthemen laut MEDLINE: Mindfulness, Mobile Applications, Smoking Cessation, Tobacco Products. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NCATS NIH HHS, Tobacco-Related Disease Research Program.
Abstract (Originalsprache)
Background
Cigarette smoking is the leading cause of preventable cancers. A majority of the 34 million people who currently smoke report wanting to quit. Mindfulness training apps offer a guided telehealth intervention to foster individuals’ behavioral meditation practice. We present the main outcomes of a parallel-group randomized controlled trial that tested app-based mindfulness training vs attention control on smoking behavior.
Methods
We enrolled adult residents from across California who smoked daily and were willing to make a quit attempt (N = 213). Participants completed daily sessions in 10-minute segments for 14 consecutive days. Participants then started a quit attempt and reported daily smoking for 28 days following the quit date using the timeline follow-back measure.
Results
Seven-day point-prevalence abstinence for each week during the 4-week quit period ranged from 21.8% to 27.7% for app-based mindfulness training and 17.9% to 19.6% for controls. The intention-to-treat sample revealed that app-based mindfulness training outperformed controls on the proportion of abstinence days during the quit period (odds ratio = 2.00, 95% confidence interval = 1.03 to 3.87, P = .041). Although the 7-day point prevalence abstinence for week 4 favored app-based mindfulness training, significance was not reached (odds ratio = 1.65, 95% confidence interval = 0.84 to 3.23, P = .148). The mean number of cigarettes smoked per day among smokers was 4.95 for app-based mindfulness training vs 5.69 for controls (odds ratio = 0.81, 95% confidence interval = 0.71 to 0.92, P = .002), suggesting harm reduction in continued smokers.
Conclusion
A mindfulness training app prescribed for 2 weeks leading up to a quit date showed an advantage over controls for total abstinence days and fewer cigarettes smoked in a diverse sample consisting of urban and rural residents. These findings yield implications for the use of apps to reduce exposure to the carcinogenic properties of cigarette smoke.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
- Norris Comprehensive Cancer Center, Cancer Control Research Division, Keck Medicine of USC, Los Angeles, CA, USA.
- Department of Psychology, University of Southern California, Los Angeles, CA, USA.
ORCID-Profile: David S Black
Förderung
- NCI NIH HHS
- NCATS NIH HHS
- Tobacco-Related Disease Research Program
Zitieren
APA
Black, D. S., & Kirkpatrick, M. G. (2023). Effect of a mindfulness training app on a cigarette quit attempt: an investigator-blinded, 58-county randomized controlled trial. JNCI Cancer Spectrum. https://doi.org/10.1093/jncics/pkad095
Vancouver
Black DS, Kirkpatrick MG. Effect of a mindfulness training app on a cigarette quit attempt: an investigator-blinded, 58-county randomized controlled trial. JNCI Cancer Spectrum. 2023. doi:10.1093/jncics/pkad095
BibTeX
@article{Black2023,
author = {Black, David S and Kirkpatrick, Matthew G},
title = {Effect of a mindfulness training app on a cigarette quit attempt: an investigator-blinded, 58-county randomized controlled trial},
journal = {JNCI Cancer Spectrum},
year = {2023},
doi = {10.1093/jncics/pkad095}
}
EUVIMED